FilingReader Intelligence

Shanghai Pharma proposes $155m dividend, plans debt issuance

March 31, 2025 at 07:40 AM UTCBy FilingReader AI

** Shanghai Pharmaceuticals Holding, a major pharmaceutical group listed on the Shanghai Stock Exchange, released its 2024 annual report outlining a proposed dividend distribution of CNY 1,371.65 million, or CNY 2.90 per 10 shares. The company achieved net profits attributable to shareholders of CNY 4,552.53 million on revenues of CNY 275,250.93 million.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Shanghai Pharmaceuticals Holding publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →